Overview

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the long-term safety and efficacy of pregabalin in patients with partial seizures.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Pregabalin